Mapping the clinical practice of traditional,complementary and integrative medicine in oncology in Western countries:A multinational cross-sectional survey  

作　　者：Matthias Huemer Sandro Graca Sarah Bitsche Guenter Hofmann Mike Armour Martin Pichler 

机构地区：[1]Palliative Care Unit,Division of Oncology,Department of Internal Medicine,Medical University of Graz,8036 Graz,Austria [2]Northern College of Acupuncture,York YO16LJ,United Kingdom [3]School of Health and Society,Faculty of Education,Health and Wellbeing,University of Wolverhampton,Wolverhampton WV11LY,United Kingdom [4]National Institute of Complementary Medicine Health Research Institute,Western Sydney University,Penrith NSW 2751,Australia [5]Translational Health Research Institute,Western Sydney University,Penrith NSW 2751,Australia [6]Medical Research Institute of New Zealand,Wellington 6021,New Zealand [7]Translational Oncology,University Hospital of Augsburg,86156 Augsburg,Germany

出　　处：《Journal of Integrative Medicine》2024年第1期64-71,共8页结合医学学报（英文版）

摘　　要：Background Many cancer patients seek adjunctive therapies to biomedical cancer treatments at some point of their disease trajectory.While acupuncture is increasingly recommended by leading oncological associations,limited evidence exists concerning the evidence-informed practice and adherence to current guidelines of traditional complementary and integrative medicine(TCIM)practitioners treating cancer patients.Methods An international online-survey assessed the demographical data,clinical practice,and sources of information used by TCIM practitioners in Austria,Germany,United States of America,Australia,and New Zealand.Results In total,404 respondents completed the survey,of which 254(62.9%)treated cancer patients.Most practitioners were acupuncturists and herbalists(57.1%),had(16.8±9.9)years of clinical experience and see a median of 2(1,4)cancer patients per week.Breast cancer(61.8%)is the most common cancer type seen in TCIM clinics.Adjunctive TCIM treatments are frequently concurrent with the patient’s cancer specific treatment(39.9%),which is also reflected by the main goal of a TCIM treatment to alleviate side effects(52.4%).However,only 28.0%of the respondents are in contact with the treating oncologist.According to the respondents,pain is most effectively treated using acupuncture,while herbal medicine is best for cancer-related fatigue.TCIM practitioners mostly use certified courses(33.1%)or online databases(28.3%)but often believe that experts are more reliable to inform their practice(37.0%)than research publications(32.7%).Conclusion Acupuncturists and herbalists commonly treat cancer patients.Most practitioners use TCIM as an adjunct to biomedicine as supportive care and use it largely in accordance with current oncological guidelines.

关 键 词：Integrative medicine ACUPUNCTURE ONCOLOGY Evidence-informed practice International survey 

分 类 号：R730.5[医药卫生—肿瘤]